Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation.

Elevated clozapine plasma concentrations and higher concentrations-by-dose were observed in patients with hypersalivation. A potential role for therapeutic drug monitoring in the prevention or management of clozapine-related hypersalivation is suggested.